What I am working with: retatrutide · 5 mg/mL.
Everything I have found on this is either a forum aside or a product page, neither of which I trust.
I am comfortable with the arithmetic; what I am missing is the procedural detail around it.
What does a defensible version of this look like in practice?
Nobody has published a cycle count, and at 5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.5 mg and every microlitre is 5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 5 mg/mL and the date, and never thaw a container you will refreeze.
The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.
Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.
| State | Condition | Usable window | Basis |
|---|---|---|---|
| Lyophilised solid | −20 °C, sealed, dry | 24–36 months | Supplier guidance |
| Lyophilised solid | 2–8 °C, sealed | 12–24 months | Supplier guidance |
| Lyophilised solid | 25 °C, sealed | 4–8 weeks | Extrapolated (Arrhenius) |
| Lyophilised solid | 40 °C, sealed | 1–2 weeks | Extrapolated |
| Solution, preserved | 2–8 °C | 28 days | USP microbiological convention |
| Solution, preserved | 25 °C | 3–7 days | Extrapolated |
| Solution, unpreserved | 2–8 °C | 24 hours | USP microbiological convention |
Windows for the solid state are chemical; windows for solution are microbiological and usually shorter than the chemical limit.
Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.
Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.
Dry powder tolerates cycles far better than solution does.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsAnswering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.
During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.
A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Let a frozen vial reach room temperature before opening, or you condense water into it.
This is one of the few handling questions with a genuinely quantitative literature behind it.
Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.
Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.
Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.
The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.
Thaw slowly and never refreeze an aliquot.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.